{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T01:12:15Z","timestamp":1716513135611},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,4]]},"DOI":"10.7759\/cureus.10790","type":"journal-article","created":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T17:32:46Z","timestamp":1601832766000},"source":"Crossref","is-referenced-by-count":1,"title":["Unveiling the Mystery of Peripartum Cardiomyopathy: A Traditional Review"],"prefix":"10.7759","author":[{"given":"Goodness  C","family":"Chinweuba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian H","family":"Rutkofsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Peripartum Cardiomyopathy","author":"Rodriguez Ziccardi M","year":"2020","unstructured":"Rodriguez Ziccardi M, Siddique MS. Peripartum Cardiomyopathy. Momin Siddique (ed): StatPearls [Internet], Treasure Island; 2020."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2018:2:2","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy","volume":"4","author":"Koenig T","year":"2018","unstructured":"Koenig T, Bauersachs J, Hilfiker-Kleiner D. Bromocriptine for the treatment of peripartum cardiomyopathy. Card Fail Rev. 2018, 4:46-49. 10.15420\/cfr.2018:2:2","journal-title":"Card Fail Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22888","article-title":"Peripartum cardiomyopathy: status","volume":"41","author":"Gupta D","year":"2018","unstructured":"Gupta D, Wenger NK. Peripartum cardiomyopathy: status. Clin Cardiol. 2018, 41:217-219. 10.1002\/clc.22888","journal-title":"Clin Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00531","article-title":"Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart","volume":"5","author":"Bollen IA","year":"2015","unstructured":"Bollen IA, Van Deel ED, Kuster DW, Van Der Velden J. Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart. Front Physiol. 2015, 5:531. 10.3389\/fphys.2014.00531","journal-title":"Front Physiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2019.05.03","article-title":"Detection and management of arrhythmias in peripartum cardiomyopathy","volume":"10","author":"Hoevelmann J","year":"2020","unstructured":"Hoevelmann J, H\u00e4hnle L, H\u00e4hnle J, Sliwa K, Viljoen C. Detection and management of arrhythmias in peripartum cardiomyopathy. Cardiovasc Diagn Ther. 2020, 10:325-335. 10.21037\/cdt.2019.05.03","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.188","article-title":"Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter\/defibrillator","volume":"16","author":"Duncker D","year":"2014","unstructured":"Duncker D, Haghikia A, K\u00f6nig T, et al.. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter\/defibrillator. Eur J Heart Fail. 2014, 16:1331-1336. 10.1002\/ejhf.188","journal-title":"Eur J Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-017-1090-5","article-title":"Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection: a German multi-centre analysis","volume":"106","author":"Duncker D","year":"2017","unstructured":"Duncker D, Westenfeld R, Konrad T, et al.. Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection: a German multi-centre analysis. Clin Res Cardiol. 2017, 106:582-589. 10.1007\/s00392-017-1090-5","journal-title":"Clin Res Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany Z","year":"2016","unstructured":"Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016, 133:1397-1409. 10.1161\/CIRCULATIONAHA.115.020491","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001056","article-title":"Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study","volume":"3","author":"Kolte D","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, et al.. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014, 3:e001056. 10.1161\/JAHA.114.001056","journal-title":"J Am Heart Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000746","article-title":"Pregnancy-related mortality in California: causes, characteristics. and improvement opportunities","volume":"125","author":"Main EK","year":"2015","unstructured":"Main EK, McCain CL, Morton CH, Holtby S, Lawton E. Pregnancy-related mortality in California: causes, characteristics. and improvement opportunities. Obstet Gynecol. 2015, 125:938-947. 10.1097\/AOG.0000000000000746","journal-title":"Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv009","article-title":"Peripartum cardiomyopathy: current management and future perspectives","volume":"36","author":"Hilfiker-Kleiner D","year":"2015","unstructured":"Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J. 2015, 36:1090-1097. 10.1093\/eurheartj\/ehv009","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu013","article-title":"Pregnancy as a cardiac stress model","volume":"101","author":"Chung E","year":"2014","unstructured":"Chung E, Leinwand LA. Pregnancy as a cardiac stress model. Cardiovasc Res. 2014, 101:561-570. 10.1093\/cvr\/cvu013","journal-title":"Cardiovasc Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi M","year":"2014","unstructured":"Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014, 130:1003-1008. 10.1161\/CIRCULATIONAHA.114.009029","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00042.2014","article-title":"The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?","volume":"306","author":"Conrad KP","year":"2014","unstructured":"Conrad KP, Davison JM. The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?. Am J Physiol Renal Physiol. 2014, 306:1121-1135. 10.1152\/ajprenal.00042.2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nature11040","article-title":"Cardiac angiogenic imbalance leads to peripartum cardiomyopathy","volume":"485","author":"Patten IS","year":"2012","unstructured":"Patten IS, Rana S, Shahul S, et al.. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012, 485:333-338. 10.1038\/nature11040","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.37","article-title":"Pathophysiology and epidemiology of peripartum cardiomyopathy","volume":"11","author":"Hilfiker\u2010Kleiner D","year":"2014","unstructured":"Hilfiker\u2010Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014, 11:364-370. 10.1038\/nrcardio.2014.37","journal-title":"Nat Rev Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware JS","year":"2016","unstructured":"Ware JS, Li J, Mazaika E, et al.. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med. 2016, 374:233-241. 10.1056\/NEJMoa1505517","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu050","article-title":"Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy","volume":"35","author":"Van Spaendonck-Zwarts KY","year":"2014","unstructured":"Van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, et al.. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J. 2014, 35:2165-2173. 10.1093\/eurheartj\/ehu050","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.931220","article-title":"Rare variant mutations in pregnancy\u2010associated or peripartum cardiomyopathy","volume":"121","author":"Morales A","year":"2010","unstructured":"Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, Hershberger RE. Rare variant mutations in pregnancy\u2010associated or peripartum cardiomyopathy. Circulation. 2010, 121:2176-2182. 10.1161\/CIRCULATIONAHA.109.931220","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16047644","article-title":"Serum selenium and ceruloplasmin in Nigerians with peripartum cardiomyopathy","volume":"16","author":"Karaye KM","year":"2015","unstructured":"Karaye KM, Yahaya IA, Lindmark K, Henein MY. Serum selenium and ceruloplasmin in Nigerians with peripartum cardiomyopathy. Int J Mol Sci. 2015, 16:7644-7654. 10.3390\/ijms16047644","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64365","article-title":"MicroRNA\u2010146a is a therapeutic target and biomarker for peripartum cardiomyopathy","volume":"123","author":"Halkein J","year":"2013","unstructured":"Halkein J, Tabruyn SP, Ricke\u2010Hoch M, et al.. MicroRNA\u2010146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest. 2013, 123:2143-2154. 10.1172\/JCI64365","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1119","article-title":"Transcoronary concentration gradients of circulating microRNAs in heart failure","volume":"20","author":"De Rosa S","year":"2018","unstructured":"De Rosa S, Eposito F, Carella C, et al.. Transcoronary concentration gradients of circulating microRNAs in heart failure. Eur J Heart Fail. 2018, 20:1000-1010. 10.1002\/ejhf.1119","journal-title":"Eur J Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.495","article-title":"MicroRNAs in heart failure: from biomarker to target for therapy","volume":"18","author":"Vegter EL","year":"2016","unstructured":"Vegter EL, van der Meer P, de Windt LJ, Pinto YM, Voors AA. MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016, 18:457-468. 10.1002\/ejhf.495","journal-title":"Eur J Heart Fail"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs J","year":"2019","unstructured":"Bauersachs J, K\u00f6nig T, van der Meer P, et al.. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019, 21:827-843. 10.1002\/ejhf.1493","journal-title":"Eur J Heart Fail"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.929646","article-title":"Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy","volume":"121","author":"Van Spaendonck-Zwarts KY","year":"2010","unstructured":"Van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, et al.. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation. 2010, 121:2169-2175. 10.1161\/CIRCULATIONAHA.109.929646","journal-title":"Circulation"},{"key":"ref26","article-title":"Peripartum cardiomyopathy: a review","volume":"39(1)","author":"Bhattacharyya A","year":"2012","unstructured":"Bhattacharyya A, Basra SS, Sen P, Kar B. Peripartum cardiomyopathy: a review. Tex Heart Inst J. 2012, 39(1):8-16.","journal-title":"Tex Heart Inst J"},{"key":"ref27","article-title":"Postpartum Cardiomyopathy","author":"Mubarik A","year":"2020","unstructured":"Mubarik A, Chippa V, Iqbal AM. Postpartum Cardiomyopathy. Arshad Muhammad Iqbal (ed): StatPearls [Internet], Treasure Island; 2020."},{"key":"ref28","article-title":"The treatment of heart failure-related symptoms with ivabradine in a case with peripartum cardiomyopathy","volume":"7","author":"Demir S","year":"2013","unstructured":"Demir S, Tufenk M, Karakaya Z, Akilli R, Kanadas M. The treatment of heart failure-related symptoms with ivabradine in a case with peripartum cardiomyopathy. Int Cardiovasc Res J. 2013, 7:33-36.","journal-title":"Int Cardiovasc Res J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s40981-019-0256-8","article-title":"Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report","volume":"5","author":"Hakata S","year":"2019","unstructured":"Hakata S, Umegaki T, Soeda T, et al.. Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report. JA Clin Rep. 2019, 5:38. 10.1186\/s40981-019-0256-8","journal-title":"JA Clin Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2217\/fca.13.63","article-title":"Earlier detection can help avoid many serious complications of peripartum cardiomyopathy","volume":"9","author":"Fett JD","year":"2013","unstructured":"Fett JD. Earlier detection can help avoid many serious complications of peripartum cardiomyopathy. Future Cardiol. 2013, 9:809-816. 10.2217\/fca.13.63","journal-title":"Future Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-014-0354-x","article-title":"Why do some recovered peripartum cardiomyopathy mothers experience heart failure with a subsequent pregnancy?","volume":"17","author":"Fett JD","year":"2015","unstructured":"Fett JD, Shah TP, McNamara DM, et al.. Why do some recovered peripartum cardiomyopathy mothers experience heart failure with a subsequent pregnancy?. Curr Treat Options Cardiovasc Med. 2015, 17:354. 10.1007\/s11936-014-0354-x","journal-title":"Curr Treat Options Cardiovasc Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/41860-unveiling-the-mystery-of-peripartum-cardiomyopathy-a-traditional-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:33Z","timestamp":1707506853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/41860-unveiling-the-mystery-of-peripartum-cardiomyopathy-a-traditional-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,4]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.10790","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,4]]}}}